SILGAN HOLDINGS INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that SILGAN HOLDINGS INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $1.05B | Mar 2, 2020 |
| FY2019 | Sep 30, 2019 | $1.32B | Mar 2, 2020 |
| FY2019 | Jun 30, 2019 | $1.09B | Mar 2, 2020 |
| FY2019 | Mar 31, 2019 | $1.03B | Mar 2, 2020 |
| FY2019 | Dec 31, 2018 | $1.07B | Mar 2, 2020 |
| FY2019 | Sep 30, 2018 | $1.31B | Mar 2, 2020 |
| FY2019 | Jun 30, 2018 | $1.06B | Mar 2, 2020 |
| FY2019 | Mar 31, 2018 | $1.01B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $995.70M | Feb 28, 2019 |
| FY2018 | Sep 30, 2017 | $1.27B | Feb 28, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.48B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $5.85B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $5.99B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $6.41B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $5.68B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $4.92B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $4.49B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $4.45B | Feb 25, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $995.70M | Mar 1, 2018 |
| FY2017 | Sep 30, 2017 | $1.27B | Mar 1, 2018 |
| FY2017 | Jun 30, 2017 | $1.02B | Mar 1, 2018 |
| FY2017 | Mar 31, 2017 | $805.41M | Mar 1, 2018 |
| FY2017 | Dec 31, 2016 | $805.89M | Mar 1, 2018 |
| FY2017 | Sep 30, 2016 | $1.14B | Mar 1, 2018 |
| FY2017 | Jun 30, 2016 | $874.64M | Mar 1, 2018 |
| FY2017 | Mar 31, 2016 | $792.74M | Mar 1, 2018 |
| FY2016 | Dec 31, 2015 | $829.62M | Mar 1, 2017 |
| FY2016 | Sep 30, 2015 | $1.20B | Mar 1, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.15B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.01B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $992.56M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $1.05B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $918.42M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $867.40M | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | $156.62M | Mar 2, 2020 |
| FY2019 | Sep 30, 2019 | $207.62M | Mar 2, 2020 |
| FY2019 | Jun 30, 2019 | $183.51M | Mar 2, 2020 |
| FY2019 | Mar 31, 2019 | $166.00M | Mar 2, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $288.40M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $276.38M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $325.97M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $340.85M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $359.08M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $308.72M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $193.81M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $223.99M | Feb 25, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $359.49M | Mar 2, 2020 |
| FY2019 | Dec 31, 2018 | $412.10M | Mar 2, 2020 |
| FY2019 | Dec 31, 2017 | $356.99M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $299.73M | Feb 28, 2019 |
| FY2017 | Dec 31, 2015 | $319.81M | Mar 1, 2018 |
| FY2016 | Dec 31, 2014 | $360.85M | Mar 1, 2017 |
| FY2015 | Dec 31, 2013 | $324.18M | Feb 25, 2016 |
| FY2014 | Dec 31, 2012 | $325.51M | Feb 27, 2015 |
| FY2013 | Dec 31, 2011 | $354.12M | Feb 28, 2014 |
| FY2012 | Dec 31, 2010 | $283.32M | Feb 28, 2013 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $492.67M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $438.39M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $384.38M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $417.02M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $378.11M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $377.68M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $315.70M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $308.38M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $305.17M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $219.93M | Feb 28, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $729.84M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $721.87M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $482.60M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $748.41M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $556.84M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $602.51M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $507.36M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $506.52M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $389.77M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $394.55M | Feb 28, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $307.09M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $262.79M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $226.81M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $215.76M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $232.26M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $224.18M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $230.94M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $190.97M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $174.43M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $191.89M | Feb 28, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.40B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $8.58B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $7.61B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $7.35B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $7.77B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $6.51B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $4.93B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $4.58B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $4.65B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $3.15B | Mar 1, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.27B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.99B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $1.89B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $1.72B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $1.56B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $1.25B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $1.02B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $881.27M | Feb 25, 2021 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.49B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.32B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $2.02B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $1.98B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $2.04B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $1.74B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $1.14B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $1.15B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $1.17B | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $604.71M | Feb 28, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.61B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $3.40B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $3.21B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $2.96B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $2.69B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $2.40B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $2.14B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $2.00B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $1.81B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $1.56B | Mar 1, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.08B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $822.85M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $642.92M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $585.62M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $631.44M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $409.48M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $203.82M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $72.82M | Mar 2, 2020 |
| FY2019 | Dec 31, 2017 | $53.53M | Mar 2, 2020 |
| FY2019 | Dec 31, 2016 | $24.69M | Mar 2, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | $1.69B | Feb 28, 2014 |
| FY2012 | Dec 31, 2012 | $1.67B | Feb 28, 2013 |
| FY2011 | Dec 31, 2011 | $1.38B | Feb 29, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 3 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Mar 2, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Mar 2, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Mar 2, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Mar 2, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Mar 2, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Mar 2, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Mar 2, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Mar 2, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 105.44M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 106.79M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | 106.50M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | 110.08M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | 110.41M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | 110.06M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | 110.78M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | 110.43M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | 110.39M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | 55.05M | Mar 1, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $85.77M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $82.06M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $78.89M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $71.95M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $62.50M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $53.64M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $50.84M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $44.55M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $40.49M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $40.88M | Feb 28, 2019 |